Betulin protects mice from bacterial pneumonia and acute lung injury

Microbial Pathogenesis

Volumn 75, Issue , 2014, Pages 21-28

  Wu, Qianchao ^a   Li, Hongyu ^a   Qiu, Jiaming ^a   Feng, Haihua ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Acute lung injury; Bacterial pneumonia; Betulin; Cytokines; Macrophages

Indexed keywords

ANTIINFLAMMATORY AGENT; BOTULINUM TOXIN; CYTOKINE; LIPOPOLYSACCHARIDE;

ACUTE LUNG INJURY; ANIMAL; BACTERIAL LOAD; C57BL MOUSE; CELL LINE; DISEASE MODEL; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; IMMUNOLOGY; LUNG; MACROPHAGE; MALE; MICROBIOLOGY; PATHOLOGY; PNEUMONIA, BACTERIAL;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; BACTERIAL LOAD; BOTULINUM TOXINS; CELL LINE; CYTOKINES; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MALE; MICE, INBRED C57BL; PNEUMONIA, BACTERIAL;

EID: 84908692664     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2014.08.005     Document Type: Article

References (38)

1. Beutz M.A., Abraham E. Community-acquired pneumonia and sepsis. Clin Chest Med 2005, 26:19-28.
2. Mizgerd J.P. Lung infection-a public health priority. PLoS Med 2006, 3(2):e76.
3. Klugman K.P. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990, 3:171-196.
4. File J.T.M. Community-acquired pneumonia. Lancet 2003, 362:1991-2001.
5. Ware L.B., Matthay M.A. The acute respiratory distress syndrome. NEngl J Med 2000, 342:1334-1349.
6. Parsons P., Worthen G.S., Moir E., Tate R., Henson P. The association of circulating endotoxin with the development of ARDS. Am Rev Respir Dis 1989, 140:294-301.
7. Rochelle L.G., Fischer B.M., Adler K.B. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells invitro. Free Radic Biol Med 1998, 24:863-868.
8. Rahman I. Oxidative stress, transcription factors and chromatin remodeling in lung inflammation. Biochem Pharmacol 2002, 64:935-942.
9. Stewart S., Jones D., Day C.P. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med 2001, 7:408-413.
10. Zhao X.J., Dong Q., Bindas J., Piganelli J.D., Magill A., Reiser J., et al. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. JImmunol 2008, 181:3049-3056.
11. Petrasek J., Dolganiuc A., Csak T., Nath B., Hritz I., Kodys K., et al. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology 2011, 53:649-660.
12. Qiu J., Niu X., Dong J., Wang D., Wang J., Li H., et al. Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of α-hemolysin. JInfect Dis 2012, 206(2):292-301.
13. Lu J., Ye S., Qin R., Deng Y., Li C.P. Effect of Chinese herbal medicine extracts on cell-mediated immunity in a rat model of tuberculosis induced by multiple drug-resistant bacilli. Mol Med Rep 2013, 8(1):227-232.
14. Alakurtti S., Taru M., Salme K., Jari Y.K. Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci 2006, 29:1-13.
15. Sami A., Taru M., Salme K., Jari Y. Pharmacological properties of the ubiquitous natural product betulin. Pharm Acta Helv 2006, 29:1-13.
16. Chichewicz R.H., Kouzi S.A. Chemistry, biological activity and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med Res Rev 2004, 24:90-114.
17. Flekhter O.B., Medvedeva N.I., Karachurina L.T., Baltina L.A., Galin F.Z., Zarudii F.S., et al. Synthesis and pharmacological activity of betulin, betulinic acid and allobetulin esters. Pharm Chem J 2005, 39:401-404.
18. Dehelean C.A., Soica C., Ledeţi I., Aluaş M., Zupko I., G Luşcan A., et al. Study of the betulin enriched birch bark extracts effects on human carcinoma cells and ear inflammation. Chem Cent J 2012, 6(1):137.
19. Zhang X., Song K., Xiong H., Li H., Chu X., Deng X. Protective effect of florfenicol on acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol 2009, 9:1525-1529.
20. Ysebaert D.K., De Greef K.E., Vercauteren S.R., Ghielli M., Verpooten G.A., Eyskens E.J., et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000, 15:1562-1574.
21. Hoogendijk A.J., Roelofs J.J., Duitman J., van Lieshout M.H., Blok D.C., van der Poll T., et al. R-roscovitine reduces lung inflammation induced by lipoteichoic acid and Streptococcus pneumoniae. Mol Med 2012, 18:1086-1095.
22. Bhatia M., Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. JPathol 2004, 202:145-156.
23. Feng Q., Ren Y., Wang Y., Ma H., Xu J., Zhou C., et al. Anti-inflammatory effect of SQC-beta-CD on lipopolysaccharide-induced acute lung injury. JEthnopharmacol 2008, 118:51-58.
24. Weiss S.J. Tissue destruction by neutrophils. NEngl J Med 1989, 320:365-376.
25. Rogerio A.P., Andrade E.L., Leite D.F., Figueiredo C.P., Calixto J.B. Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation. Br J Pharmacol 2009, 158:1074-1087.
26. Zhou H., Bian D., Jiao X., Wei Z., Zhang H., Xia Y., et al. Paeoniflorin protects against lipopolysaccharide-induced acute lung injury in mice by alleviating inflammatory cell infiltration and microvascular permeability. Inflamm Res 2011, 60:981-990.
27. Choi J.R., Lee C.M., Jung I.D., Lee J.S., Jeong Y.I., Chang J.H., et al. Apigenin protects ovalbumin-induced asthma through the regulation of GATA-3 gene. Int Immunopharmacol 2009, 9:918-924.
28. Joshua A.S., Arabinda D., Swapan K.R., Naren L.B. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 2012, 87:10-20.
29. Swantek J.L., Cobb M.H., Geppert T.D. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/MAPK. Mol Cell Biol 1997, 17:6274-6282.
30. Pope R.M., Leutz A., Ness S.A. C/EBP beta regulation of the tumor necrosis factor alpha gene. JClin Invest 1994, 94:1449-1455.
31. Feng X., Ren B., Xie W., Huang Z., Liu J., Guan R., et al. Influence of hydroxyethyl starch 130/0.4 in pulmonary neutrophil recruitment and acute lung injury during polymicrobial sepsis in rats. Acta Anaesthesiol Scand 2006, 50:1081-1088.
32. Boxer L.A., Axtell R., Suchard S. The role of the neutrophil in inflammatory diseases of the lung. Blood Cells 1990, 16:25-42.
33. Repine J.E., Beehler C.J. Neutrophils and the adult respiratory distress syndrome: two interlocking perspectives. Am Rev Respir Dis 1991, 144:251-252.
34. Strieter R.M., Standiford T.J., Huffnagle G.B., Colletti L.M., Lukacs N.W., Kunkel S.L. The good, the bad, and the ugly: the role of chemokines in models of human disease. JImmunol 1996, 156:3583-3586.
35. Shang Y., Xu S.P., Wu Y., Jiang Y.X., Wu Z.Y., Yuan S.Y., et al. Melatonin reduces acute lung injury in endotoxemic rats. Chin Med J 2009, 122:1388-1393.
36. Meduri G.U., Kohler G., Headley S., Tolley E., Stentz F., Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995, 108:1303-1314.
37. Meduri G.U., Kanangat S., Stefan J., Tolley E., Schaberg D. Cytokines IL-1beta, IL-6, and TNF-α enhance invitro growth of bacteria. Am J Respir Crit Care Med 1999, 160:961-967.
38. Porat R., Clark B.D., Wolff S.M., Dinarello C.A. Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 1991, 254:430-432.